A detailed history of Binnacle Investments Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Binnacle Investments Inc holds 36 shares of UTHR stock, worth $11,188. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36
Holding current value
$11,188
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$304.42 - $380.78 $10,959 - $13,708
36 New
36 $11.1 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.1B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Binnacle Investments Inc Portfolio

Follow Binnacle Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Binnacle Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Binnacle Investments Inc with notifications on news.